Updated Jul 16, 2026 · Last SEC filing 2026-07-07
Crinetics Pharmaceuticals, Inc. (CRNX) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-07. 4 Form 8-K material event filings were reported by CRNX in the last 90 days. 4 Form 144 notices of proposed sale were filed for CRNX stock. InsiderAlpha tracks every CRNX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001658247 |
| Form 4 filings (90d) | 10 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 4 |
| Latest Form 4 filing | 2026-07-07 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Vivaldi Coelho Rogerio | Director | S — Open-market sale | 3.0K | $40.00 | $120K | SEC | |
| WIERENGA WENDELL | Director | A — Grant or award | 5.9K | $0.00 | — | SEC | |
| Nichols Weston | Director | A — Grant or award | 5.9K | $0.00 | — | SEC | |
| Vivaldi Coelho Rogerio | Director | A — Grant or award | 5.9K | $0.00 | — | SEC | |
| Fust Matthew K | Director | A — Grant or award | 5.9K | $0.00 | — | SEC | |
| Okey Stephanie | Director | A — Grant or award | 5.9K | $0.00 | — | SEC | |
| Deardorf Caren | Director | A — Grant or award | 5.9K | $0.00 | — | SEC | |
| Bedrosian Camille L | Director | A — Grant or award | 5.9K | $0.00 | — | SEC | |
| Okey Stephanie | Director | S — Open-market sale | 608 | $36.22 | $22K | SEC | |
| Okey Stephanie | Director | S — Open-market sale | 6.3K | $35.62 | $224K | SEC | |
| Struthers Richard Scott | President & CEO | G — Bona-fide gift | 111.1K | $0.00 | — | SEC | |
| Struthers Richard Scott | President & CEO | G — Bona-fide gift | 222.2K | $0.00 | — | SEC | |
| Struthers Richard Scott | President & CEO | G — Bona-fide gift | 111.1K | $0.00 | — | SEC | |
| Struthers Richard Scott | President & CEO | G — Bona-fide gift | 111.1K | $0.00 | — | SEC | |
| Struthers Richard Scott | President & CEO | G — Bona-fide gift | 111.1K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Crinetics Pharmaceuticals, Inc. (CRNX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Struthers Richard Scott | 14 | — |
| Okey Stephanie | 4 | $246K |
| Vivaldi Coelho Rogerio | 3 | $120K |
| Deardorf Caren | 2 | — |
| Bedrosian Camille L | 2 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CRNX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live CRNX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.